type 2 diabetes

By Laura Lovett November 10, 2017
A new study reveals that artificial intelligence could be a useful tool to help patients prevent Type 2 diabetes. The study, published in the Journal of Medical Internet Research, showed that patients at risk of Type 2 diabetes who used the Lark Weight Loss Health Coach AI, dropped 2.38 percent of their baseline weight and increase the percentage of healthful meals they ate by 31 percent.  “I’m...
By Jonah Comstock August 21, 2017
A new study published today in Annals of Internal Medicine and sponsored by Dexcom shows that a continuous glucose monitor could lower the HbA1c scores of people with Type 2 diabetes, and that acceptance of the technology is high among that group as well. Right now, continuous glucose monitoring is a technology mostly used by people with Type 1 diabetes, many of whom administer insulin via an...
By Heather Mack June 16, 2017
Diabetes management is among the most active, well-funded and rapidly-evolving areas of digital health. Connected tools that allow people living with diabetes to monitor their own blood glucose levels and work with digital coaching platforms to choose the best lifestyle practices to stay healthy abound, as do analytics platforms that enable remote monitoring and more detail-rich data...
By Heather Mack March 8, 2017
San Francisco-based startup Virta Health officially launched today with a mission to reverse type 2 diabetes. Formed by a team of doctors, scientists and technologists hailing from Stanford, MIT and Harvard – and backed by $37 million from some big name investors – Virta is approaching type 2 diabetes with a goal to use personalized nutrition, one-on-one coaching and remote monitoring to reverse...
By Heather Mack February 16, 2017
Chronic disease management company Livongo is collaborating with Voluntis, the Paris, France-based company that develops companion apps for medical devices, to offer an integrated program, insulin delivery system and app for people with type 2 diabetes. Members will have access to the Livongo for Diabetes Program with Voluntis’ Insulia, the diabetes management app that received both FDA approval...
By Jonah Comstock February 9, 2017
The National Institute of Diabetes and Digestive and Kidney Diseases, a part of the National Institutes of Health, has given out $41 milion in grants to four studies that will hopefully make the artificial pancreas – a long-sought, fully automated, closed-loop system for insulin regulation – a reality. Two of the studies are underway and two more are slotted to begin recruiting in the next two...
By Jonah Comstock January 19, 2017
Updated with statement from Eli Lilly Indianapolis-based pharma company Eli Lilly recently recieved FDA 510K clearance for a new mobile app called Go Dose, a diabetes management and insulin dosing app for users of Humalog, Lilly's rapid-acting insulin. The clearance is for prescription use, but includes two versions of the app: Go Dose, for patients, and Go Dose Pro, for healthcare providers. "...
By Jonah Comstock January 4, 2017
WellDoc announced today a partnership with the American Association of Diabetes Educators (AADE), a professional membership organization of over 14,000 diabetes educators. WellDoc will incorporate educational content from AADE into its FDA-cleared, reimburseable BlueStar system for diabetes management.  "We were able to build a curriculum that will be able to be delivered in a contextually guided...
By Heather Mack July 26, 2016
San Francisco-based Omada Health, an online and mobile behavioral medicine company, announced today a partnership with the American Medical Association and a new customer, Utah-based Intermountain Healthcare system, which will offer Omada’s flagship diabetes prevention program (DPP), Prevent, to its patients. The Prevent program aims to reduce the number of adults who develop type 2 diabetes. All...
By Jonah Comstock August 11, 2015
The old Dexcom Share, with charging cradle. DexCom has partnered with Google Life Sciences to develop the next generation of DexCom's CGM -- a device that is "the size of a dime", less expensive than current CGMs, and that the companies hope will eventually replace the fingerstick glucometer. The device is not just for people with Type 1 diabetes but also for those with Type 2 diabetes. "Our...